A review of reported infectious events following rituximab therapy in pemphigus patients.

Shahrigharahkoshan, Shaghayegh; Dadkhahfar, Sahar; Mozafari, Nikoo; Shahidi-Dadras, Mohammad

Shahrigharahkoshan, Shaghayegh; Dadkhahfar, Sahar; Mozafari, Nikoo; Shahidi-Dadras, Mohammad.

Afiliação

Shahrigharahkoshan S; Faculty of medicine, Laval University, Quebec, Canada.
Dadkhahfar S; Skin research center, Shahid Beheshti University of medical sciences, Tehran, Iran.
Mozafari N; Skin research center, Shahid Beheshti University of medical sciences, Tehran, Iran.
Shahidi-Dadras M; Skin research center, Shahid Beheshti University of medical sciences, Tehran, Iran.

Dermatol Ther ; 35(3): e15264, 2022 03.

Article em En | MEDLINE | ID: mdl-34907628

Assuntos

Pênfigo; Corticosteroides; Anticorpos Monoclonais; Humanos; Fatores Imunológicos/efeitos adversos; Imunossupressores/efeitos adversos; Pênfigo/diagnóstico; Pênfigo/tratamento farmacológico; Rituximab/efeitos adversos

Palavras-chave

infectious events; pemphigus; rituximab therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pênfigo Tipo de estudo: Diagnostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google